Skip to main content
Equibles
CODX logo

CODX · Co-Diagnostics, Inc. · Documents

Track CODX — free

Use CODX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CODX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.26 -0.01 (-4.12%) At close · Nov 13 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Going-concern doubt — flagged Nov 10, 2026

Substantial doubt about the company's ability to continue as a going concern.

“As a result, management has concluded that substantial doubt exists about the Company’s ability to continue as a going concern for 12 months from the date these condensed consolidated financial statements are issued. These uncertainties create substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Nov 10, 2026
Market Cap
$2.72M
Shares
10.51M
Volume · Nov 13 591.94K Avg daily vol (3M) 1.97M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Mar 27
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $3.92M ▼ 42.5% Net loss $37.64M Diluted EPS -$1.24
2024
Mar 14
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $6.81M ▼ 80.1% Net loss $35.33M Diluted EPS -$1.20
2023
Mar 16
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $34.22M ▼ 65.0% Net loss $14.24M Diluted EPS -$0.45
2022
Showing 51–100 of 149 documents
Key facts CIK 1692415 CUSIP 189763204 13F (30d) 30 filings 20 filers Visit website Investor relations